Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Icos Corp.

Division of Eli Lilly & Co.
www.icos.com

Latest From Icos Corp.

With OTC Cialis Rights, Sanofi Launches Latest Salvo In Consumer Sector Battle

Sanofi gains rights from Eli Lilly & Co. to apply for OTC approval of Cialis in the U.S., Europe, Canada and Australia. Launching the first OTC product indicated for erectile dysfunction would mark another milestone in Sanofi CEO Chris Viebacher’s mission to move the firm into the neighborhood of global OTC leaders.

Consumer BioPharmaceutical

With OTC Cialis Rights, Sanofi Launches Latest Salvo In Consumer Sector Battle

Sanofi gains rights from Eli Lilly & Co. to apply for OTC approval of Cialis in the U.S., Europe, Canada and Australia. Launching the first OTC product indicated for erectile dysfunction would mark another milestone in Sanofi CEO Chris Viebacher’s mission to move the firm into the neighborhood of global OTC leaders.

Consumer BioPharmaceutical

Partnering Interest In Infectious Disease Space Showing Promise Beyond HCV Hotspot

Antiviral agents and vaccines for indications beyond the red-hot hepatitis C indication highlight the infectious diseases track at this year’s Therapeutic Area Partnerships conference.

BioPharmaceutical Clinical Trials

Inside Lilly Research Laboratories: A Discussion With Jan Lundberg

Unbowed by a string of recent pipeline setbacks, Lilly Research Labs' new leader speaks out about his company's current trajectory and his belief in ongoing initiatives like Chorus and a mirror fund as Lilly attempts to bridge its patent cliff.
BioPharmaceutical Research and Development Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eli Lilly & Co.
  • Senior Management
  • Paul N Clark, Pres. & CEO
    Michael A Stein, VP, CFO
    Leonard Blum, VP, Sales & Mktg.
    Clifford J Stocks, VP, Bus. Dev.
  • Contact Info
  • Icos Corp.
    Phone: (425) 485-1900
    22021 20th Ave. SE
    Bothell, WA 98021
    USA
UsernamePublicRestriction

Register